About this podcast
Boba & Biotech is a candid podcast about what it takes to develop new drugs and the ecosystem of academics, biotechs, pharma and investors behind it. Our field is often misunderstood by outsiders and insiders alike due to the poor communication habits and complex science that underlie human disease.
I, Armon Sharei, was a PhD student in chemical engineering when I was first enamoured by the idea of engineering a patient’s own cells to attack their disease. Throughout my journey, we spun out a company, SQZ Biotech, from MIT, raised $400M in investor and partnered funding from Roche, and went public on the NYSE. Eventually my board and I had a big fight, I got kicked out and started all over again!
Please join me as we chat with the people that have dedicated their careers to improving human health and how they navigate the challenges of science, money, corporate politics and the rollercoaster of clinical development. As we sip on our boba throughout these episodes, I promise the only sugar coating will be on the bubbles!
Portal Biotechnologies, headquartered in Watertown, MA, is a rapidly scaling cell-engineering platform company redefining how scientists and clinicians engineer cells across research, drug discovery, and therapeutic applications. Since launching its first product in 2024, Portal has built a network of 100+ active customers, received an $8M contract from DARPA and been deployed in most of the top 10 global pharmaceutical companies and leading academic hospitals worldwide.
Armon Sharei, PhD, is the Founder and CEO of Portal Bio. Previously, Armon founded and served as CEO of SQZ Biotech (NYSE: SQZ), where he raised over $400M, advanced three oncology clinical trials, established a $1B+ collaboration with Roche, and led the IPO. A Stanford and MIT graduate and former Harvard Postdoctoral Fellow, Dr. Sharei holds 30+ patents and has been widely recognized for his scientific and entrepreneurial leadership.
Episodes
- From the Newsroom to the C-Suite: Coaching Biotech's Best Storytellers · 47 minGuest: Mike Huckman, Principal, Huckman Group In this episode of Boba & Biotech, Armon sits down with longtime biotech communications advisor and former CNBC reporter, Mike…
- SQZ Series Part I - with Jon Gilbert Building SQZ From a Lab Bench to a Roche Deal · 56 minBacked by popular demand, we're kicking off a SQZ series on Boba & Biotech. For part I, Armon sits down with Jon Gilbert, his longtime friend and SQZ’s third employee, now…
- Robots, Cells, and the Future of Individualized Medicine · 42 minGuest: Fred Parietti In this episode of Boba & Biotech, Armon sits down with Federico ("Fred") Parietti, Co-Founder and CEO of Multiply Labs, for a conversation about bringing…
- Building Precision NanoSystems and the Road to a Danaher Exit · 33 minGuest: James Taylor In this episode of Boba & Biotech, Armon sits down with James Taylor, co-founder of Precision NanoSystems, for a candid conversation about building a…
- From PhD to Public Company: Jason Kelly on Building Ginkgo and What Comes Next · 58 minGuest: Jason Kelly In this episode of Boba & Biotech, Armon sits down with Jason Kelly, co-founder and CEO of Ginkgo Bioworks, for a conversation about what it takes to build a…
- The Biotech IPO: What Bankers See That Founders Miss · 42 minGuest: Mark Dempster In this episode of Boba & Biotech, Armon sits down with Mark Dempster, Co-Head of Healthcare Investment Banking at Stifel, to pull back the curtain on what…
- From Bench to Boardroom: What Drug Development Actually Takes · 57 minGuest: William Pao In this episode of Boba & Biotech, Armon sits down with William Pao, a physician-scientist who has run oncology R&D at Roche, served as Chief Development…
- Learning Biotech, Surviving Near-Death, and Seeing What Others Don’t · 1 h 10 minGuest:Sophia Lugo In this episode of Boba & Biotech, Sophia Lugo and I grab some delicious boba teas to explore her unconventional path into biotech and the realities of…
- Inside the Biotech Incubator: What Early Companies Get Right (and Wrong) · 44 minGuest: Adam Jenkins What actually makes or breaks a biotech startup - and why is it rarely the science? In this episode of Boba & Biotech, Adam Jenkins and I enjoy some…
- What should become a company? Lessons from an academic at the center of biotech translation · 39 minGuest: Klavs F. Jensen In this episode of Boba & Biotech, I sit down with Klavs Jensen - professor at MIT and former chair of its chemical engineering department - to explore a…
- From Lab to Company: Engineering the Next Generation of Biotech Founders · 53 minGuest: Soufiane AboulhoudaIn this episode of Boba & Biotech, over matching brown sugar milk teas (great minds, same taste), Souf Aboulhouda, co-founder of Nucleate, and I trace…
- Money Meets Molecules: What Biotech Investors Actually Care About · 43 minGuest: Ileana Pirozzi In this episode of Boba & Biotech, I grab a delicious mango-coconut sago with Ileana Pirozzi, a former biotech investor who’s stepping off the venture…
- Building and Scaling the Tools and Technologies that Underpin Lifesciences · 41 min · Season 1 Episode 3In this episode of Boba & Biotech, I go for a tasty brown sugar milk tea with Martin Madaus, former CEO of one of the biggest technology providers in our field, Millipore, for a…
- Introducing Boba & Biotech: The Only Thing We Sugarcoat is the Boba · 39 min · Season 1 Episode 2In the pilot episode of Boba & Biotech, I try out a homemade milk tea with my long time friend and colleague, Shirley Mao. The goal of this episode is to invite listeners into my…
- Welcome to Boba & Biotech, here's the scoop from Armon Sharei · 2 min · Season 1 Episode 1Biotech has a PR problem. It's messy, complex, and hard to understand from the outside looking in. That's why I'm starting Boba & Biotech. I’m Armon Sharei. You might know me…








